35 results on '"Leon, Kalet"'
Search Results
2. Characterizing steady states of genome-scale metabolic networks in continuous cell cultures
3. Stochastic approximation to the specific response of the immune system
4. Mathematical Models of the Role of IL-2 in the Interactions Between Helper and Regulatory CD4+ T Cells
5. Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
6. Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: A versatile platform for fine epitope mapping
7. Unraveling a Conserved Conformation of the FG Loop upon the Binding of Natural Ligands to the Human and Murine PD1
8. Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience
9. Deciphering PD1 activation mechanism from molecular docking and molecular dynamic simulations
10. HEK293 producing the extracellular domain HER1: Full datasets of continuous fermentation process and metabolites analysis
11. Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
12. Differential Effects of IL2Rα and IL15Rα over the Stability of the Common Beta-Gamma Signaling Subunits of the IL2 and IL15 Receptors
13. An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases
14. Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19
15. In-silico media optimization for continuous cultures using genome scale metabolic networks: the case of CHO-K1
16. Immunological self-tolerance: Lessons from mathematical modeling
17. When three is not a crowd: a Crossregulation Model of the dynamics and repertoire selection of regulatory CD4+ T cells
18. Modulation of CD4 T cell function via CD6-targeting
19. Abstract CT088: Final results of the Phase I study of nivolumab in combination with CIMAvax, an epidermal growth factor(EGF)-depleting immunotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Focus on biomarker analyses
20. Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
21. Characterizing steady states of genome-scale metabolic networks in continuous cell cultures
22. Abstract B120: Synergistic potentiation of the anti-metastatic effect of anti EGFR mAbs by its combination with immunotherapies targeting the ganglioside NGcGM3
23. Abstract B011: Human IL-2 mutant exhibits a higher antitumor efficacy and lower toxicity than wildtype IL-2 in different preclinical contexts
24. Computational proteomics pitfalls and challenges: HavanaBioinfo 2012 Workshop report
25. Phase 2 trial of epidermal growth factor (EGF) vaccine CIMAvax in combination with pembrolizumab in first line and maintenance setting in advanced non–small cell lung cancer patients.
26. Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).
27. Molecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform
28. Preclinical Efficacy of Nimotuzumab, an Anti-Egfr Monoclonal Antibody as a Single Agent Therapy in Human GBM u87mg Xenografts
29. Therapeutic Approaches to Target Cancer Stem Cells
30. How Regulatory CD25+CD4+ T Cells Impinge on Tumor Immunobiology: The Differential Response of Tumors to Therapies
31. How regulatory CD25+CD4+T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors
32. When three is not a crowd: a Crossregulation Model of the dynamics and repertoire selection of regulatory CD4+T cells
33. Mathematical Models of the impact of IL2 modulation therapies on T cell dynamics.
34. When three is not a crowd: a Crossregulation Model of the dynamics and repertoire selection of regulatory CD4+ T cells.
35. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.